Prime Medicine PRME Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies

General DynamicsGD

9M-10.9%

Pioneer Bancorp, Inc.PBFS

675K—

The Travelers CompaniesTRV

6.2M-11.6%

Phillips 66PSX

2.8M-29.3%

Pioneer Bancorp, Inc.PBFS

157.5K—

WaFd, Inc.WAFD

827.8K-1.8%

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?: Prime Medicine (PRME) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $20.88M in Q1 2026.
How has Prime Medicine's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number changed year-over-year?: Prime Medicine's share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number increased by 36.2% year-over-year, from $15.33M to $20.88M.